Pharmaceutical manufacturing is generally considered a hybrid industry, in that it has major elements of process and discrete industries, often in the same facilities. Manufacturing of ingredients follows normal process procedures, while very sophisticated packaging lines use discrete control. Building control systems that span this divide across multiple production units can be challengingwww.cechina.cn, but successful implementations are worth the effort.
　　Polpharma is a major manufacturer of pharmaceutical products and active ingredients, and is proud of the fact that it is the largest company with all Polish capital in that vertical, since going private in 2000. Its manufacturing facility is located in Starogard Gdanski, with a trade office in Warsaw and branches in foreign markets. Overall, the company has 2,600 employees.
　　The Starogard Gdanski facility is one of the largest and most modern drug manufacturing plants in Europe. Here Polpharma manufactures a wide variety of products and forms:
　　Solid forms include tabletsCONTROL ENGINEERING China版权所有, film-coated tabletsCONTROL ENGINEERING China版权所有, effervescent tabletsCONTROL ENGINEERING China版权所有, sugar coated tabletsCONTROL ENGINEERING China版权所有, and capsules. The annual manufacturing capacity of solid forms is 6 billion units.
　　Parenteral drugs include injectable preparations in polyethylene packaging and glass ampoulesCONTROL ENGINEERING China版权所有, single- and multi-dose eye drops, nasal drops, infusion fluids, and fluids for external use. In 2005, the company started up a new ampoule filling facility, constructed in compliance with strict GMP (good manufacturing practice) standards for sterile manufacturing.
　　Active pharmaceutical ingredients (API), with reactor capacity of 320,000 liters. API manufacturing facilities are regularly audited by the FDA.
　　All manufacturing units in the plant have GMP certificates issued by the Main Pharmaceutical Inspectorate and PIC/S (Pharmaceutical Inspection Cooperation Scheme). Polpharma also offers contract manufacturing services of both drug products and active pharmaceutical ingredients.
　　Polpharma has used Honeywell